Target intelligence / Profile preview

Beta-glucosidase from Agrobacterium faecalis (None established; commonly referred to as "β-glucosidase" or "Abg" in literature)

Target
None established; commonly referred to as "β-glucosidase" or "Abg" in literature
Molecular classification
Enzyme, Glycoside hydrolase, Glycosyl hydrolase family 1 (GH1)
01

Overview

Beta-glucosidase from Agrobacterium faecalis is an enzyme that catalyzes the hydrolysis of β-glucosidic bonds in various glucosides, including cellobiose and aryl glucosides, facilitating the release of glucose. It belongs to glycosyl hydrolase family 1 and exhibits a broad specificity for different substrates. Its enzymatic mechanism involves a two-step hydrolysis with formation of a glucosyl-enzyme intermediate, characteristic of retaining glycosidases. This enzyme plays key roles in microbial degradation of cellulose and organic matter in the environment, plant-microbe interactions, and basic research on enzyme mechanisms. This enzyme is primarily of interest for biochemical, ecological, and industrial applications, rather than as a direct human therapeutic target.

Other names
Beta-glucosidase from Agrobacterium faecalisAbg (used in mechanistic/biochemical literature)(Previously) Beta-glucosidase from Alcaligenes faecalis
02

Mechanism of action

Hydrolyzes β-glucosidic bonds via a two-step mechanism involving a glucosyl-enzyme intermediate and oxocarbenium ion-like transition states. Inhibitors such as cyclophellitol bind to the active site and inactivate the enzyme by covalently modifying the catalytic nucleophile.

03

Biological functions

Hydrolysis of β-glucosidic bonds in disaccharides and aryl glucosidesDegradation of cellobiose and cello-oligosaccharides to glucose (as part of cellulose hydrolysis in microbes)Involved in bioconversions in organic matter cycling and plant-microbe interaction
04

Disease associations

Other (not typically associated with human disease, but plays a role in microbial metabolism, soil ecology, and plant-microbe interactions)
05

Safety considerations

None notable or clinically relevant; not used as a therapeutic target
06

Interacting drugs

Cyclophellitol (mechanism-based inactivator, used as a biochemical tool/inhibitor)

1 more in the full profile.

07

Biomarkers

None established for clinical use; not a clinical target

Beyond the preview

Go deeper on Beta-glucosidase from Agrobacterium faecalis (None established; commonly referred to as "β-glucosidase" or "Abg" in literature).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-glucosidase from Agrobacterium faecalis (None established; commonly referred to as "β-glucosidase" or "Abg" in literature).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call